IMAX (IMAX) – Research Analysts’ Recent Ratings Changes

A number of research firms have changed their ratings and price targets for IMAX (NYSE: IMAX):

• 9/9/2026 – IMAX had its price target raised by Rosenblatt Securities from $60.00 to $65.00. They now have a “buy” rating on the stock.
• 9/5/2026 – IMAX was upgraded by Wall Street Zen from “hold” to “buy”.
• 9/4/2026 – IMAX had its price target raised by The Goldman Sachs Group, Inc. from $42.00 to $50.00. They now have a “neutral” rating on the stock.
• 9/3/2026 – IMAX had its price target raised by Roth Capital from $50.00 to $60.00. They now have a “buy” rating on the stock.
• 8/24/2026 – IMAX had its price target raised by B. Riley Financial, Inc. from $52.00 to $61.00. They now have a “buy” rating on the stock.
• 8/22/2026 – IMAX was downgraded by Wall Street Zen from “buy” to “hold”.
• 8/19/2026 – IMAX had its “buy” rating reaffirmed by Rosenblatt Securities. They now have a $60.00 price target on the stock.
• 8/10/2026 – IMAX had its price target raised by Rosenblatt Securities from $50.00 to $60.00. They now have a “buy” rating on the stock.
• 7/25/2026 – IMAX was upgraded by Wall Street Zen from “hold” to “buy”.
• 7/24/2026 – IMAX had its price target raised by Roth Capital from $48.00 to $50.00. They now have a “buy” rating on the stock.
• 7/24/2026 – IMAX had its “buy” rating reaffirmed by HC Wainwright.
• 7/24/2026 – IMAX had its price target raised by JPMorgan Chase & Co. from $47.00 to $50.00. They now have an “overweight” rating on the stock.
• 7/24/2026 – IMAX had its price target raised by Wells Fargo & Company from $41.00 to $45.00. They now have an “equal weight” rating on the stock.
• 7/24/2026 – IMAX had its price target raised by Barrington Research from $46.00 to $50.00. They now have an “outperform” rating on the stock.
• 7/24/2026 – IMAX had its price target raised by Wedbush from $46.00 to $54.00. They now have an “outperform” rating on the stock.
• 7/23/2026 – IMAX had its “neutral” rating reaffirmed by The Goldman Sachs Group, Inc.. They now have a $42.00 price target on the stock.
• 7/23/2026 – IMAX had its price target raised by Roth Capital to $48.00. They now have a “buy” rating on the stock.
• 7/20/2026 – IMAX had its price target raised by B. Riley Financial, Inc. from $48.00 to $52.00. They now have a “buy” rating on the stock.
• 7/20/2026 – IMAX had its “buy” rating reaffirmed by Rosenblatt Securities. They now have a $47.00 price target on the stock.
• 7/16/2026 – IMAX was upgraded by Weiss Ratings from “hold (c+)” to “buy (b-)”.
• 7/16/2026 – IMAX had its “equal weight” rating reaffirmed by Wells Fargo & Company. They now have a $41.00 price target on the stock, down from $47.00.
• 7/16/2026 – IMAX was downgraded by Wells Fargo & Company from “overweight” to “equal weight”. They now have a $41.00 price target on the stock.

Insider Buying and Selling at IMAX

In other IMAX news, insider Kenneth Weissman sold 8,000 shares of the stock in a transaction that occurred on Tuesday, August 25th. The shares were sold at an average price of $54.54, for a total value of $436,320.00. Following the transaction, the insider directly owned 28,205 shares in the company, valued at approximately $1,538,300.70. This trade represents a 22.10% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CFO Natasha Fernandes sold 20,000 shares of the company’s stock in a transaction on Monday, August 24th. The stock was sold at an average price of $54.63, for a total value of $1,092,600.00. Following the completion of the sale, the chief financial officer owned 35,596 shares of the company’s stock, valued at $1,944,609.48. This trade represents a 35.97% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last ninety days, insiders sold 484,757 shares of company stock valued at $25,513,021. Insiders own 20.55% of the company’s stock.

IMAX Corporation is a global leader in immersive entertainment technologies, specializing in the design, manufacture and distribution of high-resolution cameras, projectors, and proprietary software solutions that enhance both film production and theatrical exhibition. The company licenses its premium large-format system to theatre owners and filmmakers around the world, enabling audiences to experience movies with greater clarity, scale and sound fidelity. IMAX also offers turnkey theatre development services, assisting cinema operators with auditorium design, installation and custom branding to optimize the customer experience.

Founded in 1967 and headquartered in Mississauga, Ontario, IMAX has built a reputation for pioneering film-format innovations, including its patented dual 15-perforation, 70-millimeter projection system.